Literature DB >> 35110899

Surgical and Functional Outcomes of En Bloc Resection of Sacral Chordoma: a Retrospective Analysis.

Rohit Sharma1, Debashish Mukherjee1, Amiy Arnav1, R Shankaran1, Varun Kumar Agarwal1.   

Abstract

Conventional chordomas occur most commonly in the sacral region. Currently, wide local excision remains the only hope for a cure in this disease. However, given the substantial morbidity caused by sacrectomy, a delicate balance needs to be established. This study elaborates our experience in managing these complicated cases with the help of a multidisciplinary team approach and outlines the various surgical and functional outcomes of sacrectomy. This was a retrospective observational study. Ten cases of biopsy proven sacral chordoma underwent en bloc resection by a posterior approach from 2011 to 2018 after multidisciplinary evaluation. Data collected and analyzed included demographics, extent of the disease, and operative parameters such as operative time, estimated blood loss, level of vertebral resection, level and number of the most caudal nerve roots preserved, surgical margins, soft tissue, or spinal reconstruction. Postoperative outcomes included time to recurrence and neurological function at 1 year. Mean size of the tumor was 116.1 mm. Three (30%) patients had positive margins. The median time to recurrence was 32 months. Four patients eventually succumbed to the disease due to local or distant recurrence. Bladder and bowel functions were excellent in those with preserved S3. Two patients remained wheelchair bound; the rest were able to walk with or without support. Management of sacral chordoma remains an onerous journey for both the treating surgeon and the patient. A multidisciplinary team approach, with careful preservation of sacral nerve roots, negative surgical margins, and excellent postoperative rehabilitation, can achieve optimum results. © Indian Association of Surgical Oncology 2021.

Entities:  

Keywords:  Chordoma; Lumbosacral tumor; Sacrectomy; Sacrococcygeal amputation

Year:  2021        PMID: 35110899      PMCID: PMC8764000          DOI: 10.1007/s13193-021-01471-w

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN: 0975-7651


  33 in total

1.  Intensity modulated radiotherapy in the management of sacral chordoma in primary versus recurrent disease.

Authors:  Angelika Zabel-du Bois; Anna Nikoghosyan; Andrea Schwahofer; Peter Huber; Wolfgang Schlegel; Jürgen Debus; Stefanie Milker-Zabel
Journal:  Radiother Oncol       Date:  2010-11-04       Impact factor: 6.280

2.  Soft-tissue reconstruction after total en bloc sacrectomy.

Authors:  Jennifer E Kim; John Pang; Joani M Christensen; Devin Coon; Patricia L Zadnik; Jean-Paul Wolinsky; Ziya L Gokaslan; Ali Bydon; Daniel M Sciubba; Timothy Witham; Richard J Redett; Justin M Sacks
Journal:  J Neurosurg Spine       Date:  2015-03-27

3.  Experience with wound complications after surgery for sacral tumors.

Authors:  Dasen Li; Wei Guo; Huayi Qu; Rongli Yang; Xiaodong Tang; Taiqiang Yan; Shun Tang; Yi Yang; Tao Ji; Sen Dong
Journal:  Eur Spine J       Date:  2013-04-16       Impact factor: 3.134

4.  Carbon ion radiotherapy for sacral chordoma: A retrospective nationwide multicentre study in Japan.

Authors:  Yusuke Demizu; Reiko Imai; Hiroki Kiyohara; Akira Matsunobu; Masahiko Okamoto; Tomoaki Okimoto; Hiroshi Tsuji; Tatsuya Ohno; Yoshiyuki Shioyama; Kenji Nemoto; Takashi Nakano; Tadashi Kamada
Journal:  Radiother Oncol       Date:  2020-09-14       Impact factor: 6.280

5.  Long-term results: adjuvant radiotherapy in en bloc resection of sacrococcygeal chordoma is advisable.

Authors:  Wouter A Moojen; Carmen L A Vleggeert-Lankamp; Augustinus D G Krol; Sander P D Dijkstra
Journal:  Spine (Phila Pa 1976)       Date:  2011-05-01       Impact factor: 3.468

6.  Definitive high-dose photon/proton radiotherapy for unresected mobile spine and sacral chordomas.

Authors:  Yen-Lin Chen; Norbert Liebsch; Wendy Kobayashi; Saveli Goldberg; David Kirsch; Geoffrey Calkins; Stephanie Childs; Joseph Schwab; Francis Hornicek; Thomas DeLaney
Journal:  Spine (Phila Pa 1976)       Date:  2013-07-01       Impact factor: 3.468

Review 7.  Neurologic deficit after resection of the sacrum.

Authors:  R Biagini; P Ruggieri; M Mercuri; R Capanna; A Briccoli; S Perin; U Orsini; S Demitri; S Arlecchini
Journal:  Chir Organi Mov       Date:  1997 Oct-Dec

Review 8.  Diagnosis and management of sacral tumors.

Authors:  Daniel M Sciubba; Rory J Petteys; Giannina L Garces-Ambrossi; Joseph C Noggle; Matthew J McGirt; Jean-Paul Wolinsky; Timothy F Witham; Ziya L Gokaslan
Journal:  J Neurosurg Spine       Date:  2009-03

9.  Association of surgical resection and survival in patients with malignant primary osseous spinal neoplasms from the Surveillance, Epidemiology, and End Results (SEER) database.

Authors:  Debraj Mukherjee; Kaisorn L Chaichana; Scott L Parker; Ziya L Gokaslan; Matthew J McGirt
Journal:  Eur Spine J       Date:  2012-12-21       Impact factor: 3.134

Review 10.  Safety and Local Control of Radiation Therapy for Chordoma of the Spine and Sacrum: A Systematic Review.

Authors:  Brenton Pennicooke; Ilya Laufer; Arjun Sahgal; Peter P Varga; Ziya L Gokaslan; Mark H Bilsky; Yoshiya J Yamada
Journal:  Spine (Phila Pa 1976)       Date:  2016-10-15       Impact factor: 3.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.